Never relapse, invalid refund, recurrence free tracking. "eye on the" find pouch, eye lines, dark circles and other.
永不复发，无效退款，复发免费跟踪。“护眼一号”找到了眼袋、眼纹、黑眼圈等。
Because the drugs reduce cancer recurrence, finding a way to help patients stay on them is important for long-term, relapse-free survival, according to Rastelli.
根据拉斯·泰利的说法，由于这种药物可以减少癌症的复发，因此寻找一条途径帮助这些患者长期无复发的生存下去是很重要的事情。
In both groups, overall 5-year survival rate was approximately 70% and recurrence-free survival rate was about 62%.
两组患者的5年总的生存率都接近70%以及无复发的生存率大约为62%。
Results There was 25%recurrence rate in bone curettage and filling. There was no recurrence in diseased bone resection plus free fibular transplantation.
结果刮除、骨水泥充填术后复发率为25%，而游离腓骨移植病例无复发。
Results 8 cases of postoperative recurrence were found after tension-free hernioplasty, the relapse rate was 1.52%.
结果记忆弹力环补片无张力疝修补术后复发8例，复发率1.52%。
Methods Clinical and pathological data were retrospectively analyzed to compare the 18 cases suffering from postoperative local recurrence with the 21 postoperative recurrence - free survivors.
方法将结直肠癌术后局部复发18例与无复发21例的临床及病理资料进行对比分析。
The recurrence rate, disease free interval, and adverse reaction after operation were observed.
观察术后复发率和无瘤间期及不良反应发生情况。
RESULTS: The candidates' overall 3-year survival rate and recurrence-free survival rate were 67% and 70% after transplantation, respectively.
结果：在移植后，候选人全部3年存活率和无肿瘤复发存活率分别为67％、70％。
Conclusions: The operation time, hospitalization time and postoperative recurrence rate are no statistically difference between laparoscopic and tension-free hernia repair.
结论：腹腔镜疝修补术与开放式无张力疝修补手术时间、住院时间和术后复发两组无统计学差异。
Multi-modal treatment like adjuvant androgen deprivation therapy plus radiotherapy can greatly improve the biochemical recurrence-free survival.
术后辅助内分泌治疗联合放疗的综合治疗可显著延长无生化复发生存时间。
Conclusion Postoperative recurrence of tension-free is related to many reasons such as anatomy on inappropriate level, the patch is not placed to appropriate location, movement, curly, etc.
结论记忆弹力环补片无张力疝修补术后复发与解剖层次不恰当和补片放置位置不恰当、移位、卷曲等多方面因素有关。
The recurrence - free survivalrate at 3 years was 100 % .
本组肝癌病人移植术后3 年无复发生存率为100 ％ 。
Results 11 patients were free from disease postoperatively within 0.5-3 years follow up. 1 patients underwent reoperation because of recurrence.
结果11例随访05 -3年无复发，1例术后1年窦口封闭再次手术。结论除头痛外，本病早期无特殊表现。
Objective:To probe into the causes of recurrence after mesh plug tension free hernioplasty.
探讨疝环充填式疝修补术后的复发原因。
Thus, patients with RCC who received vitespen after nephrectomy showed no increased recurrence-free survival.
因此，长期存活的肾切除术后接受噬菌体接种的肾细胞癌病人显示复发率并未增高。
Conclusions This study suggests that tumor recurrence decreases and tumor free survival increases by adjuvant individualized chemotherapy after liver transplantation for HCC.
结论肝移植术后辅助个体化化疗能显著降低肝癌肝移植术后的肿瘤复发率 ，明显延长肝移植术后的无瘤生存时间。
The expression of BC2 in the patients with recurrence or metastasis was higher than that in the tumor-free survivors (P<0.05).
BC2手术后表达降低，且复发转移组表达高于无瘤生存组（P<0.05）。
The expression of BC2 in the patients with recurrence or metastasis was higher than that in the tumor-free survivors (P<0.05).
BC2手术后表达降低，且复发转移组表达高于无瘤生存组（P<0.05）。
应用推荐